Dissimilar interaction of CB1/CB2 with lipid bilayers as revealed by molecular dynamics simulation

被引:6
|
作者
Ramos, Javier [1 ]
Cruz, Victor L. [1 ]
Martinez-Salazar, Javier [1 ]
Campillo, Nuria E. [2 ]
Paez, Juan A. [2 ]
机构
[1] CSIC, Inst Estruct Mat, GEMPPO, Dept Fis Macromol, Madrid 28006, Spain
[2] CSIC, Inst Quim Med, E-28006 Madrid, Spain
关键词
PROTEIN-COUPLED RECEPTOR; CANNABINOID CB1 RECEPTOR; PARTICLE MESH EWALD; DOCKING ANALYSIS; CELL BIOLOGY; ACTIVATION; HELIX; RAFTS; ENVIRONMENTS; MEMBRANES;
D O I
10.1039/c0cp01456g
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Cannabinoid receptors CB1 and CB2 are a striking class of transmembrane proteins involved in a high number of important biological processes. In spite of the inherent similarity (40% in aminoacid sequence) these receptors are found in different cell environments. In addition to this, CB1 activity has been intimately associated with lipid rafts whereas CB2 has not. In this work we have performed a 50 nanosecond molecular dynamics simulation of the inactive conformations of both receptors inserted in a POPC lipid bilayer. Although in both cases the overall protein structure is maintained along the entire simulation we have found important differences in the protein-lipid interaction. While CB1 tends to distort the lipid bilayer regularity, especially in the extracellular moiety, CB2 has a minor influence on the lipid distribution along the plane of the bilayer. This observation is consistent with some experimental facts observed in these cannabinoid receptors with regard to lipid/protein interaction.
引用
收藏
页码:3660 / 3668
页数:9
相关论文
共 50 条
  • [21] Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B
    Dai, Erhei
    Zhang, Lianshan
    Ye, Lihong
    Wan, Shiqing
    Feng, Lulu
    Qi, Qi
    Yao, Fang
    Li, Zhen
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 59 : 124 - 130
  • [22] Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury
    Rivera, Patricia
    Vargas, Antonio
    Pastor, Antoni
    Boronat, Anna
    Jesus Lopez-Gambero, Antonio
    Sanchez-Marin, Laura
    Medina-Vera, Dina
    Serrano, Antonia
    Javier Pavon, Francisco
    de la Torre, Rafael
    Agirregoitia, Ekaitz
    Isabel Lucena, Maria
    Rodriguez de Fonseca, Fernando
    Decara, Juan
    Suarez, Juan
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (14) : 3309 - 3326
  • [23] Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors
    De Freitas, Guilherme B. L.
    da Silva, Leandro L.
    Romeiro, Nelilma C.
    Fraga, Carlos A. M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (06) : 2482 - 2496
  • [24] Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β2AR
    Latek, Dorota
    Kolinski, Michal
    Ghoshdastider, Umesh
    Debinski, Aleksander
    Bombolewski, Rafal
    Plazinska, Anita
    Jozwiak, Krzysztof
    Filipek, Slawomir
    JOURNAL OF MOLECULAR MODELING, 2011, 17 (09) : 2353 - 2366
  • [25] CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint
    Gondim, Delane Viana
    Bezerra Araujo, Joana Claudia
    Cunha Cavalcante, Andre Luiz
    Havt, Alexandre
    Quetz, Josiane da Siva
    de Castro Brito, Gerly Anne
    Ribeiro, Ronaldo de Albuquerque
    Vale, Mariana Lima
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 90 (11) : 1479 - 1489
  • [26] International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
    Pertwee, R. G.
    Howlett, A. C.
    Abood, M. E.
    Alexander, S. P. H.
    Di Marzo, V.
    Elphick, M. R.
    Greasley, P. J.
    Hansen, H. S.
    Kunos, G.
    Mackie, K.
    Mechoulam, R.
    Ross, R. A.
    PHARMACOLOGICAL REVIEWS, 2010, 62 (04) : 588 - 631
  • [27] Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
    Raich, Iu
    Rivas-Santisteban, Rafael
    Lillo, Alejandro
    Lillo, Jaume
    Reyes-Resina, Irene
    Nadal, Xavier
    Ferreiro-Vera, Carlos
    Sanchez de Medina, Veronica
    Majellaro, Maria
    Sotelo, Eddy
    Navarro, Gemma
    Franco, Rafael
    PHARMACOLOGICAL RESEARCH, 2021, 174
  • [28] Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
    Preet, Anju
    Qamri, Zahida
    Nasser, Mohd W.
    Prasad, Anil
    Shilo, Konstantin
    Zou, Xianghong
    Groopman, Jerome E.
    Ganju, Ramesh K.
    CANCER PREVENTION RESEARCH, 2011, 4 (01) : 65 - 75
  • [29] The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro
    Luca, Tonia
    Di Benedetto, Giulia
    Scuderi, Mariagrazia Rita
    Palumbo, Marco
    Clementi, Silvia
    Bernardini, Renato
    Cantarella, Giuseppina
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 616 (1-3) : 16 - 21
  • [30] Differential Regulation of MMPs, Apoptosis and Cell Proliferation by the Cannabinoid Receptors CB1 and CB2 in Vascular Smooth Muscle Cells and Cardiac Myocytes
    Greiner, Bettina
    Sommerfeld, Manuela
    Kintscher, Ulrich
    Unger, Thomas
    Kappert, Kai
    Kaschina, Elena
    BIOMEDICINES, 2022, 10 (12)